Literature DB >> 33479073

Lesson of the month: Severe granulomatosis with polyangiitis (GPA): a diagnostic challenge during the COVID-19 pandemic.

Qurratulain Qurratulain1, Azeem Ahmed2, Quentin Jones2.   

Abstract

We present the case of a 71-year-old woman with bilateral pneumonia who continued to deteriorate despite multiple courses of antibiotics. When dexamethasone was added to cover the possibility of COVID-19 pneumonia, she rapidly improved. Subsequently, she was found to have a strongly positive PR3 anti-nuclear cytoplasmic antibody (ANCA) and clinical features consistent with granulomatosis with polyangiitis (GPA) with upper respiratory tract and renal involvement. The case highlights how the COVID-19 pandemic can create new challenges in the diagnosis of GPA. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  COVID-19; anti-nuclear cytoplasmic antibodies (ANCA); atypical pneumonia; granulomatosis with polyangiitis (GPA)

Year:  2021        PMID: 33479073      PMCID: PMC7850209          DOI: 10.7861/clinmed.2020-0793

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  8 in total

Review 1.  Wegener's granulomatosis presenting as a recurrence of chronic otitis media.

Authors:  D M Hartl; P Aïdan; O Brugière; O Sterkers
Journal:  Am J Otolaryngol       Date:  1998 Jan-Feb       Impact factor: 1.808

2.  BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.

Authors:  Eleana Ntatsaki; David Carruthers; Kuntal Chakravarty; David D'Cruz; Lorraine Harper; David Jayne; Raashid Luqmani; John Mills; Janice Mooney; Michael Venning; Richard A Watts
Journal:  Rheumatology (Oxford)       Date:  2014-04-11       Impact factor: 7.580

Review 3.  The concept of limited forms of Wegener's granulomatosis.

Authors:  S M Cassan; D T Coles; E G Harrison
Journal:  Am J Med       Date:  1970-09       Impact factor: 4.965

4.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens.

Authors:  Wenling Wang; Yanli Xu; Ruqin Gao; Roujian Lu; Kai Han; Guizhen Wu; Wenjie Tan
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

5.  Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.

Authors:  U Schönermarck; P Lamprecht; E Csernok; W L Gross
Journal:  Rheumatology (Oxford)       Date:  2001-02       Impact factor: 7.580

6.  Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients.

Authors:  W D Travis; G S Hoffman; R Y Leavitt; H I Pass; A S Fauci
Journal:  Am J Surg Pathol       Date:  1991-04       Impact factor: 6.394

7.  Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.

Authors:  Jerome R Lechien; Carlos M Chiesa-Estomba; Sammy Place; Yves Van Laethem; Pierre Cabaraux; Quentin Mat; Kathy Huet; Jan Plzak; Mihaela Horoi; Stéphane Hans; Maria Rosaria Barillari; Giovanni Cammaroto; Nicolas Fakhry; Delphine Martiny; Tareck Ayad; Lionel Jouffe; Claire Hopkins; Sven Saussez
Journal:  J Intern Med       Date:  2020-06-17       Impact factor: 13.068

8.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

  8 in total
  3 in total

1.  Cytoplasmic Antineutrophil Cytoplasmic Antibodies (C-ANCA) Vasculitis: An Uncommon Complication After Stem Cell Transplantation.

Authors:  Ahmad Raja; Summia Matin Afridi; Myint M Noe; Akriti Jain
Journal:  Cureus       Date:  2022-05-29

2.  Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19.

Authors:  Serdar Can Güven; Hakan Apaydın; Bahar Özdemir; Berkan Armağan; İhsan Ateş; Abdulsamet Erden; Orhan Küçükşahin; Ahmet Omma
Journal:  Future Virol       Date:  2022-02-10       Impact factor: 1.831

Review 3.  COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis.

Authors:  Bohdana Doskaliuk; Roman Yatsyshyn; Iryna Klishch; Olena Zimba
Journal:  Rheumatol Int       Date:  2021-10-01       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.